Is it Kawasaki Disease or Multisystem Inflammatory Syndrome in Children?

Published:November 02, 2021DOI:https://doi.org/10.1016/j.nurpra.2021.08.006

      Highlights

      • Kawasaki disease should be considered in any child with a prolonged fever.
      • Multisystem inflammatory syndrome in children have similar clinical features.
      • The etiology of Kawasaki disease is unknown but is suspected to be a virus.
      • The systemic inflammation affects all the medium-sized arteries of multiple organs.
      • Early identification and treatment can prevent coronary artery abnormalities.

      Abstract

      Kawasaki disease is the leading cause of acquired heart disease in children and most frequently affects infants and young children. This disease is a systemic vasculitis that invades medium-sized arteries, including the coronary arteries. Coronary arteritis can begin as early as day 6 of fever and lead to permanent damage. Thus, early recognition and treatment significantly reduces the risk for developing coronary artery aneurysms. The overlapping clinical features of multisystem inflammatory syndrome in children secondary to COVID-19 could potentially contribute to a delay in the identification of Kawasaki disease. The clinical similarities and differences are discussed, along with recent guidelines.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fimbres A.M.
        • Shulman S.T.
        Kawasaki disease.
        Pediatr Rev. 2008; 29: 308-316https://doi.org/10.1542/pir.29-9-308
        • Gerding R.
        Kawasaki disease: a review.
        J Pediatr Health Care. 2011; 25: 379-387https://doi.org/10.1016/j.pedhc.2011.07.007
        • Sosa T.
        • Brower L.
        • Divanovic A.
        Diagnosis and management of Kawasaki disease.
        JAMA Pediatr. 2019; 173: 278https://doi.org/10.1001/jamapediatrics.2018.3307
        • Chen S.
        • Dong Y.
        • Kiuchi M.G.
        • et al.
        Coronary artery complication in Kawasaki disease and the importance of early intervention: a systematic review and meta-analysis.
        JAMA Pediatr. 2016; 170: 1156-1163https://doi.org/10.1001/jamapediatrics.2016.2055
        • McCrindle B.
        • Rowley A.
        • Newburger J.
        • et al.
        Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association.
        Circulation. 2017; 135: e927-e999https://doi.org/10.1161/CIR.0000000000000484
        • Centers for Disease Control and Prevention
        Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C).
        May 2021
      1. Kawasaki Disease in Infants & Young Children. American Academy of Pediatrics. 2020.
        • Kang J.
        • Kim Y.
        • Huh K.
        • et al.
        Reduction in Kawasaki disease after nonpharmaceutical interventions in the COVID-19 era: a nationwide observational study in Korea.
        Circulation. 2021; 143: 2508-2510https://doi.org/10.1161/CIRCULATIONAHA.121.054785
        • American Heart Association
        Pandemic prevention measures linked to lower rates of Kawasaki disease in children. June 7, 2021.
        • Fukazawa R.
        • Kobayashi J.
        • Ayusawa M.
        JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease.
        Circulation J. 2020; 84: 1348-1407https://doi.org/10.1253/circj.cj-19-1094
        • Rowley A.H.
        • Shulman S.T.
        Pathogenesis and management of Kawasaki disease.
        Expert review of anti-infective therapy. 2010; 8: 197-203https://doi.org/10.1586/eri.09.109
        • Harnden A.
        • Takahashi M.
        • Burgner D.
        Kawasaki disease.
        BMJ. 2009; 338 (b1514–b1514)https://doi.org/10.1136/bmj.b1514
        • Noval Rivas M.
        • Arditi M.
        Kawasaki disease: pathophysiology and insights from mouse models.
        Nat Rev Rheumatol. 2020; 16: 391-405https://doi.org/10.1038/s41584-020-0426-0
        • Newburger J.W.
        • Takahashi M.
        • Burns J.C.
        Kawasaki disease.
        J Am Coll Cardiol. 2016; 67: 1738-1749
        • Kobayashi T.
        • Ayusawa M.
        • Suzuki H.
        • et al.
        Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).
        Pediatr Int. 2020; 62: 1135-1138https://doi.org/10.1111/ped.14326
        • Pilania R.
        • Bhattarai D.
        • Singh S.
        Controversies in diagnosis and management of Kawasaki disease.
        World J Clin Pediatr. 2018; 7: 27-35https://doi.org/10.5409/wjcp.v7.i1.27
        • Hedrich C.M.
        • Schnabel A.
        • Hospach T.
        Kawasaki disease.
        Front Pediatr. 2018; 6https://doi.org/10.3389/fped.2018.00198
        • Esteve-Sole A.
        • Anton J.
        • Pino-Ramierez R.
        • et al.
        Similarities and differences between the immunopathogenesis of COVID-19–related pediatric multisystem inflammatory syndrome and Kawasaki disease.
        J Clin Invest. 2021; 131e144554https://doi.org/10.1172/JCI144554
        • Pouletty M.
        • Borocco C.
        • Ouldali N.
        • et al.
        Paediatric multisystem Inflammatory Syndrome temporally associated with sars-cov-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
        Ann Rheumat Dis. 2020; 79: 999-1006
        • Yeo W.S.
        • Ng Q.X.
        Distinguishing between TYPICAL Kawasaki disease and multisystem Inflammatory syndrome in children (mis-c) associated with SARS-CoV-2.
        Medical hypotheses. 2020; 144: 110263
        • Ramphul K.
        • Mejias S.
        Kawasaki disease: a comprehensive review.
        Arch Med Sci Atheroscler Dis. 2018; 3: 41-45https://doi.org/10.5114/amsad.2018.74522
        • Soni P.R.
        • Rivas M.N.
        • Aditi M.
        A comprehensive update on Kawasaki disease vasculitis and myocarditis.
        Curr Rheumatol Rep. 2020; 22: 6
        • Centers for Disease Control and Prevention
        Recommended intervals-administration of antibody and measles or varicella containing vaccine.
        • Tremoulet A.H.
        • Jain S.
        • Jone P.N.
        • et al.
        Phase I/IIa trial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm.
        J Pediatr. 2019; 215: 107-117.e12https://doi.org/10.1016/j.jpeds.2019.07.064

      Biography

      Katie Cobb Thrift, RN, is a graduate student at Clemson University, Clemson, SC, and a nurse in the Pediatric Intensive Care Unit at Spartanburg Medical Center, Spartanburg, SC; she can be contacted at [email protected] .

      Biography

      Janice S.Withycombe, PhD, RN, CCRP, and Heide S. Temples, PhD, PPCNP-BC, IBCLC, are associate professors at Clemson University School of Nursing, Greenville, SC.